MEDOCRIPTINE

This brand name is authorized in Cyprus, Hong Kong SAR China.

Active ingredients

The drug MEDOCRIPTINE contains one active pharmaceutical ingredient (API):

1
UNII 3A64E3G5ZO - BROMOCRIPTINE
 

Bromocriptine is an inhibitor of prolactin secretion and a stimulator of dopamine receptors. The areas of application of bromocriptine are divided into endocrinological and neurological indications.

 
Read more about Bromocriptine

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 MEDOCRIPTINE Tablet MPI, EU: SmPC Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
G02CB01 Bromocriptine G Genito urinary system and sex hormones → G02 Other gynecologicals → G02C Other gynecologicals → G02CB Prolactine inhibitors
Discover more medicines within G02CB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
HK Department of Health Drug Office 32888

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.